首页> 外国专利> CYCLALQUILO, LACTAMA, LACTONA AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME AND PROCEDURES TO INHIBIT THE RELEASE OF THE BETA-AMYLOID PEPTIDE AND / OR SYNTHESIS THROUGH THE USE OF SUCH COMPOUNDS.

CYCLALQUILO, LACTAMA, LACTONA AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME AND PROCEDURES TO INHIBIT THE RELEASE OF THE BETA-AMYLOID PEPTIDE AND / OR SYNTHESIS THROUGH THE USE OF SUCH COMPOUNDS.

机译:环己基环己内酰胺,内酰胺,拉克托纳及其相关化合物,药物组合物,包括相同的成分,并可以通过使用此类化合物来抑制β-淀粉样肽的释放和/或合成。

摘要

COMPOUNDS ARE SUBMITTED THAT INHIBIT THE BE - AMILOID PEPTID RELEASE AND / OR ITS SYNTHESIS AND WHICH ARE SO MUCH USEFUL IS IN THE TREATMENT OF ALZHEIMER'S DISEASE. PHARMACEUTICAL COMPOSITIONS ARE ALSO SUBMITTED THAT CONTAIN A CAPABLE COMPOUND TO INHIBIT THE RELEASE OF BE - AMILOID PEPTIDES AND / OR ITS SYNTHESIS AS WELL AS PROCEDURES FOR THE TREATMENT OF ASSOCIATION THERAPEUTIC THERMAPETIC THERAPY THERAPY THERAPY.
机译:所提交的化合物具有抑制拟南芥肽释放和/或其合成的作用,并且在治疗老年痴呆症中非常有用。还建议使用药物组合物,该组合物应具有抑制贝酰胺类肽和/或它的合成以及治疗联合疗法治疗的程序的能力。

著录项

  • 公开/公告号ES2319239T3

    专利类型

  • 公开/公告日2009-05-05

    原文格式PDF

  • 申请/专利权人 ELAN PHARMACEUTICALS INC.;ELI LILLY AND COMPANY;

    申请/专利号ES19970953208T

  • 申请日1997-12-22

  • 分类号C07D243/16;A61K31/55;A61K31/551;A61K31/5513;A61K31/5517;A61K38;A61P25/28;A61P43;C07C;C07C237/22;C07D207/26;C07D207/273;C07D211/76;C07D217/24;C07D223/10;C07D223/16;C07D223/18;C07D225/02;C07D243/12;C07D243/24;C07D243/38;C07D267/14;C07D281/10;C07D307/22;C07D307/33;C07D309/30;C07D311/76;C07D401/04;C07D401/14;C07D407/12;C07D409/12;C07D409/14;C07D487/04;C07K5/087;C07K5/113;C07K14/18;

  • 国家 ES

  • 入库时间 2022-08-21 19:23:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号